Literature DB >> 7904380

Local host response in the lower respiratory tract in nephropathia epidemica.

M Linderholm1, L Bjermer, P Juto, G Roos, T Sandström, B Settergren, A Tärnvik.   

Abstract

Various lines of evidence suggest a respiratory route of transmission of nephropathia epidemica (NE). To study the response of the respiratory tract in NE, fiberoptic bronchoscopy with bronchoalveolar lavage (BAL) was performed in 5 patients in the acute phase of the disease. Compared to a reference group of 15 healthy individuals, BAL fluid of NE patients contained significantly higher total numbers of cells (p < 0.05) and significantly higher numbers of lysozyme-positive macrophages (p < 0.01), CD8+ T cells (p < 0.01), and natural killer (NK) cells (p < 0.01). There was no significant difference in numbers of CD4+ T cells, B cells, or neutrophils. When blood samples of 16 patients were examined at various intervals after onset of NE, a significant decrease in the number of NK cells (p < 0.01) was found in the acute phase of the disease. The findings are compatible with the presence of a local host response in the lower respiratory tract to NE virus infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7904380     DOI: 10.3109/00365549309008554

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  9 in total

1.  Loss of cell membrane integrity in puumala hantavirus-infected patients correlates with levels of epithelial cell apoptosis and perforin.

Authors:  Jonas Klingström; Jonas Hardestam; Malin Stoltz; Bartek Zuber; Ake Lundkvist; Stig Linder; Clas Ahlm
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

2.  Time to revise the paradigm of hantavirus syndromes? Hantavirus pulmonary syndrome caused by European hantavirus.

Authors:  J Rasmuson; C Andersson; E Norrman; M Haney; M Evander; C Ahlm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-15       Impact factor: 3.267

Review 3.  Immune response during hantavirus diseases: implications for immunotherapies and vaccine design.

Authors:  Farides Saavedra; Fabián E Díaz; Angello Retamal-Díaz; Camila Covián; Pablo A González; Alexis M Kalergis
Journal:  Immunology       Date:  2021-03-18       Impact factor: 7.215

4.  Cytotoxic immune responses in the lungs correlate to disease severity in patients with hantavirus infection.

Authors:  J Rasmuson; J Pourazar; N Mohamed; K Lejon; M Evander; A Blomberg; C Ahlm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-12       Impact factor: 3.267

5.  Hantavirus RNA in saliva from patients with hemorrhagic fever with renal syndrome.

Authors:  Lisa Pettersson; Jonas Klingström; Jonas Hardestam; Ake Lundkvist; Clas Ahlm; Magnus Evander
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

Review 6.  Immunological mechanisms mediating hantavirus persistence in rodent reservoirs.

Authors:  Judith D Easterbrook; Sabra L Klein
Journal:  PLoS Pathog       Date:  2008-11-28       Impact factor: 6.823

7.  Cardiopulmonary involvement in Puumala hantavirus infection.

Authors:  Johan Rasmuson; Per Lindqvist; Karen Sörensen; Magnus Hedström; Anders Blomberg; Clas Ahlm
Journal:  BMC Infect Dis       Date:  2013-10-28       Impact factor: 3.090

Review 8.  Innate and adaptive immune responses against human Puumala virus infection: immunopathogenesis and suggestions for novel treatment strategies for severe hantavirus-associated syndromes.

Authors:  J Klingström; A Smed-Sörensen; K T Maleki; C Solà-Riera; C Ahlm; N K Björkström; H G Ljunggren
Journal:  J Intern Med       Date:  2019-02-17       Impact factor: 8.989

9.  Comparison of Lymphocyte Populations in Patients With Dobrava or Puumala orthohantavirus Infection.

Authors:  Katarina Resman Rus; Andreja Nataša Kopitar; Miša Korva; Alojz Ihan; Miroslav Petrovec; Tatjana Avšič-Županc
Journal:  Front Cell Infect Microbiol       Date:  2020-10-16       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.